Patent · US Active

Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination

US8630703B2 · kind B2 · utility

1Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2012
Grant dateJan 14, 2014
Priority date
Expiry dateMar 8, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N5/062
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Hydrophobic weak base compounds such as hydrophobic weak base chemotherapeutic agents (which are not an anthracycline) for use in the treatment of medical conditions such as proliferative disease or disorder in a subject, in combination with illumination of a region in a body of the subject which is characterized by the presence of proliferating cells, are disclosed. The hydrophobic weak base compound and a wavelength of illumination are selected such that the hydrophobic weak base compound acts as a therapeutically effective photosensitizer when exposed to the illumination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.